Karina W. Davidson

Last updated
Karina W. Davidson
Education Queen's University, B.A. University of Waterloo, M.A.Sc., Ph.D.
TitleSenior Vice President of Research, Northwell Health

Dean of Academic Affairs, Director and Professor, Institute of Health System Science, Feinstein Institutes for Medical Research

Donald and Barbara Zucker Professor in Health Outcomes, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Contents

Website https://feinstein.northwell.edu/institutes-researchers/our-researchers/karina-davidson-phd

Karina W. Davidson is senior vice president of research at Northwell Health and director of the Institute of Health System Science at the Feinstein Institutes of Medical Research. She was previously vice-dean of organizational effectiveness and executive director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center. She was also Chief Academic Officer at NewYork-Presbyterian Hospital in New York City. [1]

Education

Davidson received her education in Canada, earning her B.A. degree with honors from Queen's University in Kingston, Ontario, Canada and her M.A.Sc. in Industrial and Organizational Psychology and her Ph.D. in Clinical Psychology from the University of Waterloo in Waterloo, Ontario. She also served as a health and child clinical psychology intern at Kitchener-Waterloo Hospital [2] and has been licensed in psychology by the Nova Scotia, Ontario, and Alabama Boards of Examiners and by the University of the State of New York Education Department.[ citation needed ]

Career

Davidson received her first faculty appointment in 1991 from Dalhousie University in Halifax, Nova Scotia as assistant professor of psychology. In 1996, she became assistant professor of psychology at the University of Alabama, where she became tenured associate professor in 2000. She then moved to New York, where she was at Mount Sinai School of Medicine in the division of Cardiology for the next three years. In 2003, Davidson was appointed co-director of the Center of the Behavioral Cardiovascular Health at Columbia University Medical Center. She became Director of the Center in 2008, and in her position as tenured professor of medicine, Cardiology, and Psychiatry she oversaw a team of researchers who study how behavior, health disparities, and psychosocial factors affect the biology and incidence of hypertension and heart disease. In 2016, she became Vice-Dean of Organizational Effectiveness for Columbia University College of Physicians & Surgeons and Chief Academic Officer at NewYork-Presbyterian Hospital. [3] Her portfolio for these two leadership positions focuses on clinical learning environment innovation for medical students and residents and executive leadership training programs for the next generation of medical school and hospital leaders. [4] [5] [ citation needed ] For more than 25 years, Dr. Davidson has served in leadership roles for teams focused on the advancement of scientific, educational and patient care missions through both the generation and implementation of evidence-based practices. She has been the principal investigator of more than 30 federally funded grants and authored over 375 peer-reviewed articles. [6] Dr. Davidson is also past chair of the United States Preventive Services Task Force.

Research Focus

While working at Dalhousie University, Davidson became keenly interested in the relationship between psychosocial risk factors and their role in the course and outcome of cardiovascular disease. Since then, she has been the recipient of numerous National Institutes of Health (NIH) grants and has authored a number of high impact studies which have contributed to the evidence base of behavioral cardiology, a new frontier in the field of cardiology.

In a study of the association between anger expression and coronary heart disease (CHD), Davidson and colleagues found that men who constructively expressed anger had a lower incident rate of CHD, but that destructive anger justification increased the rate. [7] Another paper from the same study showed that increased positive affect was associated with a lower risk of CHD. This was the first prospective study published to investigate this relationship. [8]

Davidson has conducted multiple randomized, controlled trials for managing anger or depression to examine possible improvements in quality of life, cardiovascular, and cost outcomes. [9] [10] In these studies, patients with depression following acute coronary syndrome (ACS) were found to have significantly decreased symptoms if they were given enhanced treatment (including having their preferred form of treatment) than those given usual care after 6 months.

During the course of her Directorship at CBCH, Davidson has developed team-wide expertise in systematic review methods, and in 2006 she founded the Cochrane Behavioral Medicine Field, an international effort to synthesize and disseminate evidence for behavioral medicine interventions.

Davidson continues to be a prolific researcher and has authored over 375 peer-reviewed articles, numerous editorials and book chapters, served as editor for various handbooks, and served on multiple scientific journal editorial boards. [11] Her recent research includes an N-of-1 study in cancer survivors to identify potential treatments for depression, collaborating with NewYork-Presbyterian Hospital to look at means of increasing patient flow through the emergency department, and acting as the Resource and Coordinating Center for the NIH's Science of Behavior Change Research Network.

Dr. Davidson's current research focuses on innovations in personalized trials to manage chronic disease and patient symptoms that incorporate patient preferences and values. She has conducted randomized controlled trials on depression screening and treatments for healthy, hypertensive, and cardiac patients. Dr. Davidson was awarded the National Institutes of Health Transformative R01 grant to accomplish Personalized Trial (N-of-1) clinical trial delivery at the point of care. The vision of this grant is to reimagine the process by which therapies are tested in the clinical encounter to ultimately identify for each patient the therapy that provides maximal benefit and minimal harm.

Awards and memberships

Davidson has won numerous awards and accolades for research, teaching, and mentoring, including a Distinguished Teaching award from the University of Alabama Arts and Science School, a Distinguished Service Award and a Distinguished Science Award from the Society for Behavioral Medicine, a Career Service Award from the Health Psychology Division of the American Psychological Association, a European Health Psychology Fellow award, and, most recently, the Columbia University Medical Center/Irving Institute Mentor of the Year.

Davidson has served the professional bodies in her field at the highest levels, as President of the Health Psychology Division of the American Psychological Association, and as President of the Academy of Behavioral Medicine Research. She is also a serving member of the United States Preventative Services Task Force and is currently the Chair of the National Heart, Lung and Blood Institute (NHLBI) joint Council-Board of External Experts Strategic Planning Committee. She was elected to the National Academy of Medicine in 2023 and inducted in 2024. [12] [13]

Selected publications

  1. Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations. KW Davidson, CM Mangione, MJ Barry, WK Nicholson, MD Cabana, ... JAMA 327 (12), 1171-1176
  2. Actions to Transform US Preventive Services Task Force Methods to Mitigate Systemic Racism in Clinical Preventive Services. KW Davidson, CM Mangione, MJ Barry, MD Cabana, AB Caughey, ..JAMA 326 (23), 2405-2411
  3. Davidson KW, Kemper AR, Doubeni CA, Tseng CW, Simon MA, Kubik M, Curry SJ, Mills J, Krist A, Ngo-Metzger Q and Borsky A. Developing Primary Care-Based Recommendations for Social Determinants of Health: Methods of the U.S. Preventive Services Task Force. Ann Intern Med. 2020;173:461-467.
  4. Incorporation of social risk in US Preventive Services Task Force recommendations and identification of key challenges for primary care. KW Davidson, AH Krist, CW Tseng, M Simon, CA Doubeni, AR Kemper, ...Jama 326 (14), 1410-1415
  5. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement. KW Davidson, MJ Barry, CM Mangione, M Cabana, AB Caughey, ...Jama 326 (12), 1186-1191
  6. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M and Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA.2020;323: 2052–2059.
  7. Evidence-based behavioral medicine: what is it and how do we achieve it? KW Davidson, M Goldstein, RM Kaplan, PG Kaufmann, GL Knatterud, Annals of behavioral medicine 26 (3), 161-171
  8. Shaffer JA, Kronish IM, Falzon L, Cheung YK and Davidson KW. N-of-1 Randomized Intervention Trials in Health Psychology: A Systematic Review and Methodology Critique. Ann Behav Med. 2018;52:731-742.
  9. Moise N, Wood D, Kuen KCY, Duan N, Onge TS, Duer-Hefele J, Pu T, Davidson KW, Kronish IM and members of the "Personalized Trial C. Patient preferences for Personalized (N-of-1) Trials: A conjoint analysis. J Clin Epidemiol. 2018;102:12-22.
  10. Wasson LT, Cusmano A, Meli L, Louh I, Falzon L, Hampsey M, Young G, Shaffer J and Davidson KW. Association Between Learning Environment Interventions and Medical Student Well-being: A Systematic Review. JAMA. 2016;316:2237-2252.

PubMed

Related Research Articles

<span class="mw-page-title-main">Cardiology</span> Branch of medicine dealing with the heart

Cardiology is the study of the heart. Cardiology is a branch of medicine that deals with disorders of the heart and the cardiovascular system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists, a sub-specialty of internal medicine. Pediatric cardiologists are pediatricians who specialize in cardiology. Physicians who specialize in cardiac surgery are called cardiothoracic surgeons or cardiac surgeons, a specialty of general surgery.

<span class="mw-page-title-main">Coronary artery disease</span> Reduction of blood flow to the heart

Coronary artery disease (CAD), also called coronary heart disease (CHD), ischemic heart disease (IHD), myocardial ischemia, or simply heart disease, involves the reduction of blood flow to the cardiac muscle due to build-up of atherosclerotic plaque in the arteries of the heart. It is the most common of the cardiovascular diseases. Types include stable angina, unstable angina, and myocardial infarction.

<span class="mw-page-title-main">Angina</span> Chest discomfort from heart muscles

Angina, also known as angina pectoris, is chest pain or pressure, usually caused by insufficient blood flow to the heart muscle (myocardium). It is most commonly a symptom of coronary artery disease.

<span class="mw-page-title-main">Cardiovascular disease</span> Class of diseases that involve the heart or blood vessels

Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.

<span class="mw-page-title-main">Hypercholesterolemia</span> High levels of cholesterol in the blood

Hypercholesterolemia, also called high cholesterol, is the presence of high levels of cholesterol in the blood. It is a form of hyperlipidemia, hyperlipoproteinemia, and dyslipidemia.

<span class="mw-page-title-main">Physical examination</span> Process by which a medical professional investigates the body of a patient for signs of disease

In a physical examination, medical examination, clinical examination, or medical checkup, a medical practitioner examines a patient for any possible medical signs or symptoms of a medical condition. It generally consists of a series of questions about the patient's medical history followed by an examination based on the reported symptoms. Together, the medical history and the physical examination help to determine a diagnosis and devise the treatment plan. These data then become part of the medical record.

<span class="mw-page-title-main">Hypertriglyceridemia</span> High triglyceride blood levels

Hypertriglyceridemia is the presence of high amounts of triglycerides in the blood. Triglycerides are the most abundant fatty molecule in most organisms. Hypertriglyceridemia occurs in various physiologic conditions and in various diseases, and high triglyceride levels are associated with atherosclerosis, even in the absence of hypercholesterolemia and predispose to cardiovascular disease.

The lipid hypothesis is a medical theory postulating a link between blood cholesterol levels and the occurrence of cardiovascular disease. A summary from 1976 described it as: "measures used to lower the plasma lipids in patients with hyperlipidemia will lead to reductions in new events of coronary heart disease". It states, more concisely, that "decreasing blood cholesterol [...] significantly reduces coronary heart disease".

The United States Preventive Services Task Force (USPSTF) is "an independent panel of experts in primary care and prevention that systematically reviews the evidence of effectiveness and develops recommendations for clinical preventive services". The task force, a volunteer panel of primary care clinicians with methodology experience including epidemiology, biostatistics, health services research, decision sciences, and health economics, is funded, staffed, and appointed by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.

Albert Siu is a Cuban American internist and geriatrician and the Ellen and Howard C. Katz Chairman and Professor of the Brookdale Department of Geriatrics and Palliative Medicine at Mount Sinai Hospital in New York City. He is also the director of the Geriatric Research, Education, and Clinical Center at the James J. Peters VA Medical Center in The Bronx, a senior associate editor of Health Services Research, a senior fellow of the Brookdale Foundation and a former trustee of the Nathan Cummings Foundation.

Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.

Steven E. Nissen is an American cardiologist, researcher and patient advocate. He was chairman of cardiovascular medicine at the Cleveland Clinic, in Cleveland, Ohio.

Jean-Claude Tardif is the Director of the Research Center at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. He received his medical degree (MD) in 1987 from the University of Montreal and specialized in cardiology and research in Montreal and Boston until 1994. Dr. Tardif holds the Canada Research Chair in personalized medicine and the University of Montreal endowed research chair in atherosclerosis. He is also the Scientific Director of the Montreal Health Innovations Coordinating Center (MHICC).

Overscreening, also called unnecessary screening, is the performance of medical screening without a medical indication to do so. Screening is a medical test in a healthy person who is showing no symptoms of a disease and is intended to detect a disease so that a person may prepare to respond to it. Screening is indicated in people who have some threshold risk for getting a disease, but is not indicated in people who are unlikely to develop a disease. Overscreening is a type of unnecessary health care.

Ulf Landmesser is a German specialist for cardiology and internal medicine. He is professor at the Institute for Health Research in Berlin and Head of the Medical Clinic of Cardiology at the Charité in Berlin. Landmesser is known for his work on coronary interventions and modern methods of catheter-based heart valve therapy.

Thomas G. Pickering was a British physician and academic. He was a professor of medicine at College of Physicians and Surgeons, Columbia University Medical Center in New York City. He was an internationally renowned expert in clinical hypertension and a leader in the fields of hypertension and cardiovascular behavioral medicine. He coined the term "white-coat hypertension" to describe those whose blood pressure was elevated in the doctor's office, but normal in everyday life. He later published the first editorial describing "masked hypertension". He also discovered and gave his name to the Pickering Syndrome, where bilateral renal artery stenosis causes flash pulmonary edema.

<span class="mw-page-title-main">Kirsten Bibbins-Domingo</span> American epidemiologist and physician

Kirsten Bibbins-Domingo is an American epidemiologist and physician. She is the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network. She is Professor of Epidemiology and Biostatistics and the Lee Goldman, MD Endowed Professor of Medicine at University of California, San Francisco. She is a general internist and attending physician at San Francisco General Hospital.

Dr. Robert S. Rosenson is a Professor of Medicine and also lending his services as the Director of cardio metabolic disorders at the Icahn School of Medicine at Mount Sinai.

<span class="mw-page-title-main">Erin D. Michos</span> American cardiologist and researcher

Erin Kathleen Donnelly Michos is an American cardiologist. She is an associate professor of Medicine and Director of Women's Cardiovascular Health at Johns Hopkins School of Medicine. Michos is also an Associate Faculty of the Welch Center for Prevention, Epidemiology and Clinical Research at Johns Hopkins, and has a joint faculty appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health.

Ronald P. Karlsberg is an American academic and cardiologist. He is a clinical professor of medicine at the Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA, specializing in clinical, preventive, and interventional cardiology.

References

  1. ↑ Davidson, Karina (June 14, 2017). "Karina Davidson". Columbia Cardiology. Retrieved June 14, 2017.
  2. ↑ "Biography - US Preventive Services Task Force". www.uspreventiveservicestaskforce.org. Retrieved 2017-07-31.
  3. ↑ "Karina Davidson: Increasing Organizational Effectiveness at P&S". Columbia University Medical Center. 2016-06-03. Retrieved 2017-07-31.
  4. ↑ cmm_admin (2016-05-29). "News in Brief". Columbia Medicine Magazine. Retrieved 2017-07-31.
  5. ↑ "Biography - US Preventive Services Task Force". www.uspreventiveservicestaskforce.org. Retrieved 2017-07-31.
  6. ↑ "Karina Davidson - Search Results - PubMed". PubMed. Retrieved 2023-11-16.
  7. ↑ Davidson KW, Mostofsky E. Anger expression and risk of coronary heart disease: Evidence from the Nova Scotia Health Survey. Am Heart J. 2010;159(2):199-206.
  8. ↑ Davidson KW, Mostofsky E, Whang W. Don’t worry, be happy: Positive affect and reduced 10-year incident coronary heart disease: The Canadian Nova Scotia Health Survey. Eur Heart J. 2010;31(9):1065-1070.
  9. ↑ Davidson KW, Bigger JT, Burg MM, et al. Centralized, Stepped, Patient Preference-Based Treatment for Patients With Post-Acute Coronary Syndrome Depression: CODIACS Vanguard Randomized Controlled Trial. JAMA Intern Med. 2013;173(11):997-1004.
  10. ↑ Davidson KW, Rieckmann N, Clemow L, et al. Enhanced Depression Care for Patients With Acute Coronary Syndrome and Persistent Depressive Symptoms: Coronary Psychosocial Evaluation Studies Randomized Controlled Trial. Arch Intern Med. 2010;170(7):600-608.
  11. ↑ "Don't worry, be happy! Positive emotions protect against heart disease".
  12. ↑ Allen, Julianne Mosher (2023-10-09). "Two Northwell leaders named to the National Academy of Medicine | Northwell Health". feinstein.northwell.edu. Retrieved 2023-11-16.
  13. ↑ "National Academy of Medicine Elects 100 New Members". National Academy of Medicine. 9 October 2023. Retrieved 9 October 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.